• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿呼吸窘迫综合征中磷脂酰甘油(PG)的缺乏。对新生儿次要表面活性物质磷脂的研究。

Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn. Study of the minor surfactant phospholipids in newborns.

作者信息

Hallman M, Feldman B H, Kirkpatrick E, Gluck L

出版信息

Pediatr Res. 1977 Jun;11(6):714-20. doi: 10.1203/00006450-197706000-00003.

DOI:10.1203/00006450-197706000-00003
PMID:577302
Abstract

Phosphatidylglycerol (PG) was absent from lung effluent in 41 infants with respiratory distress syndrome of the newborn (RDS), whereas effluent from healthy control subjects of similar gestational age contained this phospholipid (4.9 +/- 2.4% of lipidphosphorus (P), n = 32). Control infants of 28 weeks of gestation or less with various respiratory disturbances other than RDS also had low PG (0.2 +/- 0.2% of lipid-P, n = 5). In RDS surfactant complex often could be isolated from the airways using differential and density gradient centrifugation. The material thus obtained had prominent phosphatidylinositol (PI) (13.6 +/- 2.8% of lipid-P, n = 6), but no PG. Of those 18 infants who had such surfactant even in the early stages of RDS, 13 were 35 weeks of gestation or more, 3 were offspring of diabetic mothers, and 2 had severe perinatal asphyxia. In healthy control subjects PG sometimes appeared first within an hour of birth, but in RDS PG did not appear until recovery from RDS. In RDS type II (transient tachypnea of the newborn) PG in lung effluent also was abnormally low (1.3 +/- 0.6% of lipid-P, n = 5) and PI was correspondingly prominent (9.7 +/- 3.6% of lipid-P, n = 5), indicating immaturity of surfactant similar to RDS. Surfactant with PG and PI has superior surface-active properties compared to that containing PI, but no PG. Surfactant without PG does not seem to stabilize the alveoli of the newborn as well as does surfactant with PG. The failure of PG appearance following birth therefore may precipitate RDS, especially beyond 35 weeks of gestation.

摘要

41例新生儿呼吸窘迫综合征(RDS)患儿的肺流出液中不存在磷脂酰甘油(PG),而胎龄相似的健康对照受试者的流出液中含有这种磷脂(占脂质磷(P)的4.9±2.4%,n = 32)。28周及以下患有除RDS之外各种呼吸障碍的对照婴儿PG水平也较低(占脂质P的0.2±0.2%,n = 5)。在RDS中,通常可使用差速离心和密度梯度离心从气道中分离出表面活性剂复合物。如此获得的物质中磷脂酰肌醇(PI)含量显著(占脂质P的13.6±2.8%,n = 6),但没有PG。在18例即使在RDS早期阶段也有这种表面活性剂的婴儿中,13例胎龄为35周或以上,3例为糖尿病母亲的后代,2例有严重围产期窒息。在健康对照受试者中,PG有时在出生后1小时内首次出现,但在RDS中,PG直到从RDS恢复后才出现。在新生儿II型(暂时性呼吸急促)中,肺流出液中的PG也异常低(占脂质P的1.3±0.6%,n = 5),PI相应地显著(占脂质P的9.7±3.6%,n = 5),表明表面活性剂不成熟,类似于RDS。与含有PI但没有PG的表面活性剂相比,含有PG和PI的表面活性剂具有更好的表面活性特性。没有PG的表面活性剂似乎不如含有PG的表面活性剂那样能很好地稳定新生儿的肺泡。因此,出生后PG未出现可能会引发RDS,尤其是在胎龄超过35周时。

相似文献

1
Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn. Study of the minor surfactant phospholipids in newborns.新生儿呼吸窘迫综合征中磷脂酰甘油(PG)的缺乏。对新生儿次要表面活性物质磷脂的研究。
Pediatr Res. 1977 Jun;11(6):714-20. doi: 10.1203/00006450-197706000-00003.
2
Phospholipids in tracheal effluent from infants with severe respiratory distress syndrome.患有严重呼吸窘迫综合征的婴儿气管流出物中的磷脂
Am J Perinatol. 1984 Apr;1(3):208-13. doi: 10.1055/s-2007-1000006.
3
[Tracheal phospholipid composition and respiratory distress syndrome of the newborn].[气管磷脂成分与新生儿呼吸窘迫综合征]
Fortschr Med. 1979 Mar 8;97(9):403-8.
4
Improving the prediction of surfactant deficiency in very low-birthweight infants with respiratory distress.改善对患有呼吸窘迫的极低出生体重儿表面活性剂缺乏症的预测。
J Perinatol. 1992 Jun;12(2):129-33.
5
Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure.表面活性剂替代对呼吸窘迫综合征肺流出物磷脂的影响:表面活性剂磷脂周转、储备量评估及其与呼吸衰竭严重程度的关系。
Pediatr Res. 1986 Dec;20(12):1228-35. doi: 10.1203/00006450-198612000-00008.
6
[The lung phospholipid content in newborn infants with idiopathic respiratory distress syndrome in relation to lung histology and survival time (author's transl)].特发性呼吸窘迫综合征新生儿的肺磷脂含量与肺组织学及生存时间的关系(作者译)
Wien Klin Wochenschr. 1976 Sep 17;88(17):554-7.
7
Role of myoinositol in regulation of surfactant phospholipids in the newborn.肌醇在新生儿表面活性物质磷脂调节中的作用。
Early Hum Dev. 1985 Jan;10(3-4):245-54. doi: 10.1016/0378-3782(85)90055-6.
8
RDS and tracheal phospholipid composition in twins: independent of gestational age.双胞胎中的呼吸窘迫综合征与气管磷脂成分:与胎龄无关。
J Pediatr. 1977 May;90(5):799-802. doi: 10.1016/s0022-3476(77)81255-9.
9
Endogenous surfactant metabolism in newborn infants with and without respiratory failure.患有和未患呼吸衰竭的新生儿的内源性表面活性物质代谢
Pediatr Res. 2003 Aug;54(2):185-91. doi: 10.1203/01.PDR.0000075084.56255.E0. Epub 2003 May 7.
10
Inherited disorders of neonatal lung diseases.新生儿肺部疾病的遗传性疾病。
Turk J Pediatr. 2004 Apr-Jun;46(2):105-14.

引用本文的文献

1
Effect of Amphotericin B on the Thermodynamic Properties and Surface Morphology of the Pulmonary Surfactant Model Monolayer during Respiration.两性霉素 B 对呼吸过程中肺表面活性剂模型单层热力学性质和表面形态的影响。
Molecules. 2023 Jun 18;28(12):4840. doi: 10.3390/molecules28124840.
2
Influence of InP/ZnS Quantum Dots on Thermodynamic Properties and Morphology of the DPPC/DPPG Monolayers at Different Temperatures.不同温度下 InP/ZnS 量子点对 DPPC/DPPG 单层膜热力学性质和形态的影响。
Molecules. 2023 Jan 22;28(3):1118. doi: 10.3390/molecules28031118.
3
Biophysical analysis of gelatin and PLGA nanoparticle interactions with complex biomimetic lung surfactant models.
明胶与聚乳酸-羟基乙酸共聚物纳米颗粒与复杂仿生肺表面活性剂模型相互作用的生物物理分析
RSC Adv. 2022 Sep 30;12(43):27918-27932. doi: 10.1039/d2ra02859j. eCollection 2022 Sep 28.
4
Effects of Carboxyl or Amino Group Modified InP/ZnS Nanoparticles Toward Simulated Lung Surfactant Membrane.羧基或氨基修饰的InP/ZnS纳米颗粒对模拟肺表面活性物质膜的影响
Front Bioeng Biotechnol. 2021 Aug 19;9:714922. doi: 10.3389/fbioe.2021.714922. eCollection 2021.
5
Molecular Mechanisms of Maternal Diabetes Effects on Fetal and Neonatal Surfactant.母体糖尿病对胎儿及新生儿表面活性物质影响的分子机制
Children (Basel). 2021 Apr 6;8(4):281. doi: 10.3390/children8040281.
6
The Potential Role of Bioactive Plasmalogens in Lung Surfactant.生物活性缩醛磷脂在肺表面活性剂中的潜在作用。
Front Cell Dev Biol. 2021 Feb 16;9:618102. doi: 10.3389/fcell.2021.618102. eCollection 2021.
7
Evaluation of surfactant function at birth determined by the stable microbubble test in term and near term infants with respiratory distress.通过稳定微泡试验评估足月儿和近足月儿呼吸窘迫时出生时的表面活性剂功能。
Eur J Pediatr. 2004 Aug;163(8):443-8. doi: 10.1007/s00431-004-1473-2. Epub 2004 Jun 8.
8
Differentiation of type II cells of human fetal lung in vitro.人胎肺Ⅱ型细胞的体外分化
Cell Tissue Res. 1981;220(1):17-25. doi: 10.1007/BF00209962.
9
Metabolic fate of fatty acids in type II cells isolated from adult rat lung.成年大鼠肺中分离出的II型细胞内脂肪酸的代谢命运
Lung. 1982;160(5):267-73. doi: 10.1007/BF02719300.
10
Isolated type II cells from fetal lung as model in studies on the synthesis and secretion of pulmonary surfactant.从胎肺中分离出的II型细胞作为肺表面活性物质合成与分泌研究的模型。
Lung. 1980;158(4):177-92. doi: 10.1007/BF02713722.